Clinical expression of autoimmune diseases in older adults (Q74777722)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Clinical expression of autoimmune diseases in older adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Mishra N

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Kammer GM

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

Clinics in geriatric medicine

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

515-542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

Inclusion body myositis: clinical and pathological boundaries

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Methotrexate therapy in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Cardiac abnormalities in polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Senile dry skin type Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Prognostic factors in lupus nephritis. Contribution of renal histologic data

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Occult systemic lupus erythematosus in elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Late onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Clinical features of systemic lupus erythematosus: differences related to race and age of onset

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Discrete lung involvement in systemic lupus erythematosus: CT assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Sjögren's syndrome: a study of its neurological complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Deforming arthritis of the hands in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The relationship of dermatomyositis and polymyositis to internal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Inclusion body myositis, a review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Polymyositis: its presentation, morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Systemic lupus erythematosus in 50 year olds

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Prognostic determinants in lupus nephritis: a long-term clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Prevalence of primary Sjögren's syndrome in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Microvascular changes in early and advanced dermatomyositis: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Systemic lupus erythematosus in the elderly: clinical and immunological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Sjögren's syndrome. Proposed criteria for classification

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Dermatomyositis without creatine kinase elevation. A poor prognostic sign

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Systemic lupus erythematosus in later life.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Spontaneous skin tearing during systemic corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Inclusion body myositis and myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Polymyositis--treatment and prognosis. A study of 107 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Antiviral therapy of acute herpes zoster in older patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Survey of the prognosis for dermatomyositis, with special reference to its association with malignancy and pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Mortality from polymyositis and dermatomyositis in the United States, 1968-1978.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Presentation, treatment, and prognosis of idiopathic inflammatory muscle disease in a rural hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Systemic lupus erythematosus presenting as polymyalgia rheumatica in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The etiology of psychiatric symptoms in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Prevalence of selected autoantibodies in different elderly subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Invited review: peripheral neuropathy in Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Prevalence of eyelid dermatitis in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Microvascular deposition of complement membrane attack complex in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Polymyositis-dermatomyositis and malignant lesions: does an association exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Course of renal pathology in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Side effects of corticosteroid therapy. Psychiatric aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Inclusion body myositis. Observations in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Is chloroquine obsolete in treatment of rheumatic disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Treatment of inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Factors affecting survivorship in polymyositis. A life-table study of 124 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Polymyositis and Dermatomyositis: Combined Methotrexate and Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Sjögren's syndrome (Sicca syndrome): current issues

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Nephrocalcinosis in Sjögren's syndrome: a late sequela of renal tubular acidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Current management of polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Types of atrophic gastritis in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Osteoporosis of rheumatoid arthritis: Influence of age, sex and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Articular manifestations of polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Liver involvement in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

A reference guide to drugs and dry mouth

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Lupus and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Sjögren's syndrome and autoimmunity in a geriatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Age influences the clinical and serologic expression of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2818%2930104-6

7 January 2021

10.1016/S0749-0690(18)30104-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664105%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference